Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antihistamine
|
| gptkbp:activeIngredient |
gptkb:loratadine
|
| gptkbp:approvedBy |
gptkb:FDA
1993 |
| gptkbp:ATCCode |
gptkb:R06AX13
|
| gptkbp:availableOn |
gptkb:sugar
gptkb:tablet chewable tablet |
| gptkbp:brand |
gptkb:loratadine
|
| gptkbp:chemicalFormula |
gptkb:C22H23ClN2O2
|
| gptkbp:contraindication |
severe liver impairment
|
| gptkbp:excretion |
urine
feces |
| gptkbp:genericAvailable |
yes
|
| gptkbp:halfLife |
8 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Claritin
|
| gptkbp:legalStatus |
over-the-counter
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:Europe gptkb:United_States |
| gptkbp:metabolism |
liver
|
| gptkbp:OTC |
yes
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:prescriptionRequired |
no
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
drowsiness dry mouth |
| gptkbp:usedFor |
allergic rhinitis
urticaria |
| gptkbp:bfsParent |
gptkb:Bayer
gptkb:MRK |
| gptkbp:bfsLayer |
5
|